{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:45:40Z","timestamp":1793090740753,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejvs.2021.04.003","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T09:15:23Z","timestamp":1622625323000},"page":"225-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Long Term Survival and Limb Salvage in Patients With Non-Revascularisable Chronic Limb Threatening Ischaemia"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-9706","authenticated-orcid":false,"given":"Maarten C.","family":"Verwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep G.J.","family":"Wijnand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6751-6752","authenticated-orcid":false,"given":"Martin","family":"Teraa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne C.","family":"Verhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert J.","family":"de Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2021.04.003_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/bjs.10657","article-title":"Cardiovascular and all-cause mortality in patients with intermittent claudication and critical limb ischaemia","volume":"105","author":"van Haelst","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2147\/VHRM.S209241","article-title":"The burden of critical limb ischemia: a review of recent literature","volume":"15","author":"Duff","year":"2019","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.ejvs.2021.04.003_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ejvs.2021.04.003_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1583\/13-4375MR.1","article-title":"Clinically-driven need for secondary interventions after Endovascular revascularization of tibial arteries in patients with critical limb ischemia","volume":"20","author":"Baumann","year":"2013","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2021.04.003_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12933-016-0446-x","article-title":"Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: Results from the ADVANCE-ON study","volume":"15","author":"Mohammedi","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ejvs.2021.04.003_bib6","first-page":"205","article-title":"Percutaneous transluminal angioplasty in patients with infrapopliteal arterial disease","volume":"31","author":"Mustapha","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2021.04.003_bib7","first-page":"1047","article-title":"Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease","volume":"76","author":"Schmidt","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2021.04.003_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejvs.2012.07.017","article-title":"Angiographic restenosis and its clinical impact after infrapopliteal angioplasty","volume":"44","author":"Iida","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib9","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jvs.2015.07.065","article-title":"The natural history of untreated severe or critical limb ischemia","volume":"62","author":"Abu Dabrh","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-2007-1020350","article-title":"The ischaemic leg: A long term follow up with special reference to the predictive value of the systolic digital blood pressure. Part I: No arterial reconstruction","volume":"37","author":"Andersen","year":"1989","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.0954-6820.1986.tb02768.x","article-title":"Peripheral arterial disease\u2014natural outcome","volume":"220","author":"Lassila","year":"1986","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ejvs.2021.04.003_bib12","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jvs.2010.02.020","article-title":"Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia","volume":"51","author":"Sprengers","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","volume":"131","author":"Teraa","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2021.04.003_bib14","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jvs.2018.02.028","article-title":"Prognostic value of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification in patients with no-option chronic limb-threatening ischemia","volume":"68","author":"van Haelst","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-44176-5","article-title":"Review of the long term effects of autologous bone-marrow mononuclear cell implantation on clinical outcomes in patients with critical limb ischemia","volume":"9","author":"Yusoff","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejvs.2021.04.003_bib16","article-title":"Determinants of long term outcomes and costs in the management of critical limb ischemia: A population-based cohort study","volume":"7","author":"Mustapha","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5 Suppl","key":"10.1016\/j.ejvs.2021.04.003_bib17","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1016\/j.jvs.2010.01.077","article-title":"Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making","volume":"51","author":"Bradbury","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/ehv006","article-title":"Peripheral arterial disease and critical limb ischaemia: Still poor outcomes and lack of guideline adherence","volume":"36","author":"Reinecke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2021.04.003_bib19","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.2147\/CIA.S137570","article-title":"Mortality after major amputation in elderly patients with critical limb ischemia","volume":"12","author":"Klaphake","year":"2017","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.ejvs.2021.04.003_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00836","article-title":"Risk of contralateral lower limb amputation and death after initial lower limb amputation \u2013 a population-based study","volume":"4","author":"Huseynova","year":"2018","journal-title":"Heliyon"},{"key":"10.1016\/j.ejvs.2021.04.003_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.amjsurg.2003.07.027","article-title":"Major lower extremity amputations at a Veterans Affairs hospital","volume":"186","author":"Cruz","year":"2003","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jvs.2011.10.089","article-title":"Improved amputation-free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement","volume":"55","author":"Benoit","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib23","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/mt.2012.52","article-title":"Cellular therapy with ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial","volume":"20","author":"Powell","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.ejvs.2021.04.003_bib24","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jvs.2010.07.044","article-title":"Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial","volume":"52","author":"Powell","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jvs.2008.03.042","article-title":"Long term results of combined common femoral endarterectomy and iliac stenting\/stent grafting for occlusive disease","volume":"48","author":"Chang","year":"2008","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jvs.2006.03.026","article-title":"Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization","volume":"44","author":"Marston","year":"2006","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1078-5884(96)80044-X","article-title":"Outcome of unreconstructed chronic critical leg ischaemia","volume":"11","author":"Lep\u00e4ntalo","year":"1996","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib28","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2021.04.003_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0895-4356(00)00305-X","article-title":"Are randomized clinical trials good for us (in the short term)? Evidence for a \u201ctrial effect","volume":"54","author":"Braunholtz","year":"2001","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ejvs.2021.04.003_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2288-7-30","article-title":"The Hawthorne Effect: a randomised, controlled trial","volume":"7","author":"McCarney","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejvs.2021.04.003_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12885-020-06916-z","article-title":"Are cancer patients better off if they participate in clinical trials? A mixed methods study","volume":"20","author":"Engelbak Nielsen","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejvs.2021.04.003_bib32","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1177\/2047487319855145","article-title":"What is the best way of organizing the follow up of patients with cardiovascular disease?","volume":"26","author":"Scherrenberg","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ejvs.2021.04.003_bib33","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1001\/archinte.168.20.2194","article-title":"Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network","volume":"168","author":"Giannuzzi","year":"2008","journal-title":"Arch Intern Med"},{"issue":"1 Suppl","key":"10.1016\/j.ejvs.2021.04.003_bib34","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.ejvs.2019.04.009","article-title":"Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization","volume":"58","author":"Simons","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib35","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.jvs.2017.04.048","article-title":"Influence of frailty on treatment outcomes after revascularization in patients with critical limb ischemia","volume":"66","author":"Morisaki","year":"2017","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2021.04.003_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.006778","article-title":"Impact of frailty on clinical outcomes in patients with critical limb ischemia","volume":"11","author":"Takeji","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2021.04.003_bib37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.pcad.2018.03.003","article-title":"Next generation endovascular therapies in peripheral artery disease","volume":"60","author":"Bunte","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"issue":"1 Suppl","key":"10.1016\/j.ejvs.2021.04.003_bib38","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588421002987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588421002987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:55:54Z","timestamp":1761047754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588421002987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1078588421002987"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2021.04.003","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long Term Survival and Limb Salvage in Patients With Non-Revascularisable Chronic Limb Threatening Ischaemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2021.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}